Entities / Company
KALA BIO, Inc..
Czech company
- Reports this week
- 1
- Active events
- 1
- Connections
- 19
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
One to three months ago
-
KALA BIO, Inc. ownership structure as of September 5, 2025, includes 40% owned by retail investors, 26% by hedge funds, and Baker Bros. Advisors LP as the largest shareholder.Some support1 report1 development inside
-
KALA BIO, Inc. stock is trading on the Nasdaq exchange, with institutional inflows and outflows impacting its price.Some support5 reports
-
Ashley Weaver, representing the Kentucky FFA Foundation, was involved in an event where Fords established an agriculture department.Some support1 report
Gone quiet
No new reports in 90+ days-
KALA BIO, Inc. appointed Todd Bazemore as CEO and confirmed the CHASE trial is Phase 2b, leveraging the MSC-S platform.Some support1 report
-
KALA BIO, Inc. received Orphan Drug and Fast Track designations from the Food and Drug Administration on September 3, 2025.Some support3 reports
-
Kala BIO hosted an event featuring a director from Scripps Clinic Medical Group on July 7, 2025.Speculative1 report
-
Analyst coverage sparked interest in stocks involving Kala and Graham on July 25, 2025.Some support2 reports1 development inside
No events began in the chosen period. Widen it, or reset.
Around KALA BIO, Inc. this week
News at the entities that move KALA BIO, Inc. most-
MSC StructuralMSC launched direct and feeder services linking Karachi with Europe, capitalizing on shifting trade routes amid Middle East turmoil.Moves KALA BIO, Inc.
-
Nasdaq Shared contextGolub Capital BDC, Inc. listed on the electronic stock exchange.Moves KALA BIO, Inc.
-
Ford Mentioned togetherFord's Garage, a restaurant business, operates in Florida under the management of Marc Brown.Moves KALA BIO, Inc.
Connections
The 5 strongest of 19, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
MSC Structural
Kala's pipeline development for ocular diseases is structurally dependent on MSC's MSC-S platform.
-
Nasdaq Shared context
Kala Bio is a company that operates and is listed on the Nasdaq stock exchange.
-
Makurdi Shared context
KALA BIO, Inc. was observed operating and selling products within the geographical context of Makurdi.
-
Ashley Weaver Mentioned together
No discernible relationship established between KALA BIO, Inc. and Ashley Weaver based on the provided evidence.
-
Ford Mentioned together
Evidence is insufficient to establish any relationship between KALA BIO, Inc. and Ford.
History
Events by the month they beganNovember 2026
1 eventSeptember 2026
1 eventAugust 2026
1 eventShow 1 earlier month
June 2026
5 events- KALA BIO, Inc. ownership structure as of September 5, 2025, includes 40% owned by retail investors, 26% by hedge funds, and Baker Bros. Advisors LP as the largest shareholder.
- KALA BIO, Inc. appointed Todd Bazemore as CEO and confirmed the CHASE trial is Phase 2b, leveraging the MSC-S platform.
- KALA BIO, Inc. received Orphan Drug and Fast Track designations from the Food and Drug Administration on September 3, 2025.
- Kala BIO hosted an event featuring a director from Scripps Clinic Medical Group on July 7, 2025.
- Analyst coverage sparked interest in stocks involving Kala and Graham on July 25, 2025.